Enovis (ENOV) Income from Non-Controlling Interests (2012 - 2026)
Enovis (ENOV) reported Income from Non-Controlling Interests of $314000.0 for Q2 2026, up 20.31% year-over-year from $261000.0 in Q2 2025, and up 132.59% on a QoQ basis from $135000.0 in Q4 2025.
Enovis (ENOV) has 15 years of Income from Non-Controlling Interests data on file, last reported at $314000.0 in Q2 2026.
- Quarterly Income from Non-Controlling Interests rose 20.31% year-over-year to $314000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $873000.0 (up 11.49% YoY) and the FY2025 annual result came in at $820000.0, up 20.77% from the prior year.
- Income from Non-Controlling Interests advanced to $314000.0 in Q2 2026 per ENOV's latest filing, from $135000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $314000.0 in Q2 2026 and bottomed at $34000.0 in Q4 2022.
- The 5-year median for Income from Non-Controlling Interests is $157000.0 (2024), against an average of $169411.8.
- The widest annual swing landed in 2022, when Income from Non-Controlling Interests sank 84.26%; it then soared 547.5% in 2024.
- Tracing ENOV's Income from Non-Controlling Interests over 5 years: stood at $34000.0 in 2022, then soared by 241.18% to $116000.0 in 2023, then climbed by 18.1% to $137000.0 in 2024, then declined by 1.46% to $135000.0 in 2025, then surged by 132.59% to $314000.0 in 2026.
- Per Business Quant, the three latest ENOV Income from Non-Controlling Interests figures stand at $314000.0 (Q2 2026), $135000.0 (Q4 2025), and $233000.0 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | 314,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 314,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Oct 3, 2025 | 233,000.00 |
| Jul 4, 2025 | 191,000.00 |
| Apr 4, 2025 | 261,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 27, 2024 | 259,000.00 |
| Jun 28, 2024 | 126,000.00 |
| Mar 29, 2024 | 157,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 29, 2023 | 40,000.00 |
| Jun 30, 2023 | 182,000.00 |
| Mar 31, 2023 | 192,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 136,000.00 |
| Jul 1, 2022 | 100,000.00 |
| Apr 1, 2022 | 267,000.00 |
| Dec 31, 2021 | 216,000.00 |
| Oct 1, 2021 | 818,000.00 |
| Jul 2, 2021 | 355,000.00 |
| Apr 2, 2021 | 876,000.00 |
| Dec 31, 2020 | 211,000.00 |
| Oct 2, 2020 | 789,000.00 |
| Jul 3, 2020 | 427,000.00 |
| Apr 3, 2020 | 1.03 Mn |
| Dec 31, 2019 | 1.53 Mn |
| Sep 27, 2019 | 2.32 Mn |
| Jun 28, 2019 | 2.63 Mn |
| Mar 29, 2019 | 4.02 Mn |
| Dec 31, 2018 | 2.56 Mn |
| Sep 28, 2018 | 3.89 Mn |
| Jun 29, 2018 | 3.32 Mn |
| Mar 30, 2018 | 4.51 Mn |
| Dec 31, 2017 | 4.55 Mn |
| Sep 29, 2017 | 5.84 Mn |
| Jun 30, 2017 | 5.08 Mn |
| Mar 31, 2017 | 2.95 Mn |
| Dec 31, 2016 | 5.05 Mn |
| Sep 30, 2016 | 4.23 Mn |
| Jul 1, 2016 | 4.21 Mn |
| Apr 1, 2016 | 3.60 Mn |
| Dec 31, 2015 | 4.33 Mn |
| Sep 25, 2015 | 5.19 Mn |
| Jun 26, 2015 | 5.70 Mn |
| Mar 27, 2015 | 4.22 Mn |
| Dec 31, 2014 | 5.66 Mn |
| Sep 26, 2014 | 7.91 Mn |
| Jun 27, 2014 | 6.56 Mn |
| Mar 28, 2014 | 8.05 Mn |
| Dec 31, 2013 | 7.07 Mn |
| Sep 27, 2013 | 10.00 Mn |
| Jun 28, 2013 | 8.81 Mn |
| Mar 29, 2013 | 4.64 Mn |
| Dec 31, 2012 | 5.33 Mn |
| Sep 28, 2012 | 5.41 Mn |
| Jun 29, 2012 | 6.27 Mn |
| Mar 30, 2012 | 5.14 Mn |